BioTek’s Synergy Neo2 Hybrid Multi-Mode Microplate Reader received expanded certification from Cisbio Bioassays for their proprietary HTRF technology, a TR-FRET assay platform used in the Life Sciences. Synergy Neo2 was recently updated with an optional TRF laser. The TRF laser provides ultra-fast measurement speed, along with optimal sensitivity for critical screening applications like Time-Resolved Fluorescence (TRF) and Time-Resolved Fluorescence Energy Transfer (TR-FRET) assays. Synergy Neo2 now offers HTRF certification with both its flash lamp and laser excitation modes and is an ideal solution for high throughput screening (HTS) and core labs facilitating ultra-fast processing of high-throughput biochemical and cell-based assay workflows.
“Optimizing a cellular or biochemical assay starts by choosing the right instrumentation and detection mode” explains Xavier Amouretti, Product Management Director at BioTek. “This is the key to the consistent assay performance necessary for the researchers who trust BioTek. Matching the new certified Synergy Neo2 TRF Laser option with the popular Cisbio proprietary HTRF technology brings the ultimate in speed and performance to many core and HTS screening laboratories.”
BioTek’s other current HTRF-certified detection systems include the Synergy H1 Hybrid Multi-Mode Reader as well as the Cytation 1 and Cytation 5 Cell Imaging Multi-Mode Readers.
SOURCE: BioTek Instruments, Inc.